Skip to Content

WPI 2775 (Metformin 850 mg)

Pill imprint WPI 2775 has been identified as Metformin hydrochloride 850 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metformin hydrochloride 850 mg WPI 2775
Discount Card Promo
Metformin hydrochloride
Imprint:
WPI 2775
Strength:
850 mg
Color:
Orange
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-2775
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
hypromellose
lactose monohydrate
ferric oxide red
titanium dioxide
triacetin
vanillin
yellow iron oxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide